Drug intelligence / Profile preview

pectin

Development stage
Phase 2
Lead developer
Jinling Hospital
Modality
Microbiome Therapeutics
Administration
Oral
01

Overview

Pectin is a heterogeneous plant-derived polysaccharide and soluble dietary fiber composed mainly of galacturonic acid-rich chains with variable methyl esterification and neutral sugar side chains. In the provided public sources, it is being investigated as a therapeutic nutritional adjunct rather than as a conventional pharmaceutical active ingredient, particularly for improving tolerance to enteral nutrition and reducing diarrhea in critically ill patients, and has also been studied preclinically for anti-inflammatory, lipid-lowering, and anticancer effects. Its proposed mechanisms are multifactorial and formulation/source dependent, including increasing luminal viscosity and semi-solidifying enteral feeds, fermentation by gut microbiota to short-chain fatty acids, and direct modulation of innate immune signaling such as Toll-like receptor 2 and Toll-like receptor 4 pathways, with downstream suppression of inflammatory cytokines including interleukin-6. Because \"pectin\" is a broad, structurally variable natural substance rather than a single well-defined molecular entity, activity can differ substantially by source and preparation such as citrus, orange, apple, or modified pectin.

Brand names
PX pectin
Other names
果胶citrus pectinorange pectinapple pectinmodified pectinmodified citrus pectin
02

Targets

TLR2 (Toll-like Receptor 2)TLR1TLR4 (Toll-like receptor 4)LGALS3 (Galectin-3)

Beyond the preview

Go deeper on pectin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on pectin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call